Trefoil Therapeutics has a total of 34 patents globally, out of which 9 have been granted. Of these 34 patents, more than 85% patents are active. The USA is where Trefoil Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and Hong Kong. Parallelly, the USA seems to be the main focused R&D center of Trefoil Therapeutics and is also the origin country of the firm.
Trefoil Therapeutics was founded in the year 2014 by David Eveleth, Kenneth Thomas, Michael Blaber and Ralph Bradshaw. The company is a biotechnology firm that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.
Do read about some of the most popular patents of Trefoil Therapeutics which have been covered by us in this article and also you can find Trefoil Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Trefoil Therapeutics patent portfolio.
How many patents does Trefoil Therapeutics have?
Trefoil Therapeutics has a total of 34 patents globally. These patents belong to 7 unique patent families. Out of 34 patents, 29 patents are active.
How Many Patents did Trefoil Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Trefoil Therapeutics Applications Filed | Trefoil Therapeutics Patents Granted |
| 2022 | 4 | 1 |
| 2021 | 3 | 1 |
| 2020 | 3 | 5 |
| 2019 | 1 | 2 |
| 2018 | 8 | – |
| 2017 | 3 | – |
| 2016 | – | – |
| 2015 | – | – |
| 2014 | 11 | – |
| 2013 | – | – |
| 2012 | – | – |
| 2011 | – | – |
How many Trefoil Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Trefoil Therapeutics File in Different Countries?
Countries in which Trefoil Therapeutics Filed Patents
| Country | Patents |
| United States Of America | 5 |
| Europe | 5 |
| Hong Kong (S.A.R.) | 2 |
| Israel | 1 |
| Slovenia | 1 |
| Poland | 1 |
| Denmark | 1 |
| Taiwan | 1 |
| Austria | 1 |
| Mexico | 1 |
| Germany | 1 |
| Singapore | 1 |
| Brazil | 1 |
| Spain | 1 |
| Canada | 1 |
| Croatia | 1 |
| India | 1 |
| Australia | 1 |
| Hungary | 1 |
Where are Research Centres of Trefoil Therapeutics Patents Located?
List of Trefoil Therapeutics Patents
| Trefoil Therapeutics Patents | Title |
| US11479591B2 | Recombinant Modified Fibroblast Growth Factors And Therapeutic Uses Thereof |
| US11103553B2 | Modified Fibroblast Growth Factors For The Treatment Of Ocular Disorders |
| US20230130851A1 | Recombinant Modified Fibroblast Growth Factors And Therapeutic Uses Thereof |
| US20210338777A1 | Modified Fibroblast Growth Factors For The Treatment Of Ocular Disorders |
| EP3049100B1 | Modified Fibroblast Growth Factors-1 For The Treatment Of Ocular Disorders |
| EP4172351A1 | Recombinant Modified Fibroblast Growth Factors And Therapeutic Uses Thereof |
| EP3619324A4 | Recombinant Modified Fibroblast Growth Factors And Therapeutic Uses Thereof |
| EP3666791A1 | Modified Fibroblast Growth Factors-1 For The Treatment Of Ocular Disorders |
| EP3436608A4 | Modified Fibroblast Growth Factors And Uses Thereof |
| WO2023043743A1 | Methods Of Treatment Using Modified Fgf-1 Polypeptides |
| WO2023019218A1 | Modified Fibroblast Growth Factors For Treating Fibrotic Diseases |
| HRP20200257T1 | Modified Fibroblast Growth Factors For The Treatment Of Ocular Disorders |
| ES2773574T3 | Modified Fibroblast Growth Factors 1 For The Treatment Of Eye Disorders |
| PL3049100T3 | Modified Fibroblast Growth Factors-1 For The Treatment Of Ocular Disorders |
| SI3049100T1 | Modified Fibroblast Growth Factors-1 For The Treatment Of Ocular Disorders |
| DK3049100T3 | Modified Fibroblast Growth Factors-1 For The Treatment Of Eye Disorders |
| DE602014057264T2 | Modified Fibroblast Growth Factor-1 For Treatment Of Eye Diseases |
| HUE051295T2 | Modified Fibroblast Growth Factors-1 For The Treatment Of Ocular Disorders |
| AT1203418T | Modifizierter Fibroblasten-Wachstumsfaktor-1 Zur Behandlung Von Augenerkrankungen |
| AU2018261021A1 | Recombinant Modified Fibroblast Growth Factors And Therapeutic Uses Thereof |
| CA3062473A1 | Recombinant Modified Fibroblast Growth Factors And Therapeutic Uses Thereof |
| HK40030921A | Modified Fibroblast Growth Factors-1 For The Treatment Of Ocular Disorders |
| HK40019822A | Recombinant Modified Fibroblast Growth Factors And Therapeutic Uses Thereof |
| IL270385A | Recombinant Modified Fibroblast Growth Factors And Therapeutic Uses Thereof |
| IN202317000197A | Recombinant Modified Fibroblast Growth Factors And Therapeutic Uses Thereof |
| TW202327641A | Methods Of Treatment Using Modified Fgf-1 Polypeptides |
| BR112019023260A2 | Growth Factors Of Modified Recombinant Fibroblasts And Their Therapeutic Uses |
| MX2019013210A | Recombinant Modified Fibroblast Growth Factors And Therapeutic Uses Thereof. |
| SG11201910305TA | Recombinant Modified Fibroblast Growth Factors And Therapeutic Uses Thereof |
| US20210009650A1 | Modified Fibroblast Growth Factors And Uses Thereof |
| WO2021263134A1 | Recombinant Modified Fibroblast Growth Factors And Therapeutic Uses Thereof |
| WO2018204847A2 | Recombinant Modified Fibroblast Growth Factors And Therapeutic Uses Thereof |
| WO2017172525A2 | Modified Fibroblast Growth Factors And Uses Thereof |
| WO2015048188A8 | Modified Fibroblast Growth Factors For The Treatment Of Ocular Disorders |
What are Trefoil Therapeutics’ key innovation segments?
What Technologies are Covered by Trefoil Therapeutics?
The chart below distributes patents filed by Trefoil Therapeutics